K2 Principal Fund, L.P. Vivos Therapeutics, Inc. Put Options Transaction History
K2 Principal Fund, L.P.
- $197 Million
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
About Vivos Therapeutics, Inc.
- Ticker VVOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 23,012,100
- Market Cap $60.3M
- Description
- Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...